ARMI | BioFabUSA will participate in MHSRS 2025 biomanufacturing efforts by showcasing advanced regenerative medicine technologies aimed at improving warfighter recovery and readiness. As a national leader in biofabrication, ARMI is committed to translating medical innovations into scalable solutions that support the unique needs of military medicine.
Our exhibit will feature breakthroughs in engineered tissue, biofabricated grafts, and manufacturing platforms designed to restore function and improve outcomes for wounded service members. These innovations are developed through strong collaboration between government, industry, and academic partners.
ARMI representatives will also participate in key sessions focused on regenerative medicine, tissue engineering, and advanced manufacturing in combat casualty care. We’re proud to contribute to the MHSRS community and its vital mission of delivering better care for warfighters at home and abroad.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
